Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.60    1.05 (16.03%)
Bid:
7.20
Ask:
8.00
Spread: 0.80 (11.111%)
Market Cap: £9.08m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Half Yearly Report

21 Dec 2011 07:00

RNS Number : 3716U
Marechale Capital PLC
21 December 2011
 



21 December 2011

 

Marechale Capital plc

("Marechale" or the "Company")

 

Interim Results

 

Marechale Capital plc today announces its unaudited interim results for the six months ended 30 September 2011.

 

Chairman's Statement

 

Marechale has had an encouraging start to the current year, particularly in the context of the current economic environment, and I am able to report that, whilst recording a loss during the half year to September, the Company has successfully completed a number of transactions and generated revenues which are in line with our budget to date. Indeed, in the last week the Company has arranged the funding for the £38m acquisition of seven hotels by a Halcyon Hotels & Resorts plc joint venture (http://www.marechalecapital.com/our-deals/deals/38m-acquisition-for-halcyon-hotels), which has to date returned the business to profitability. We have a healthy pipeline of projects and believe that we are on track to achieve our target for the year to March 2012.

 

Marechale operates as a corporate finance advisory and capital fund raising business focusing on fundraising for growth companies and funds in three sectors in which the team have a long term track record: Leisure and Retail, Renewable Energy and Online Exchanges.

 

Marechale helps management teams to finance or refinance in two key areas of activity; Growth Capital private equity transactions for more established businesses, and Development Capital, fundraising for smaller growth companies, the latter typically being Enterprise Investment Scheme (EIS) qualifying. As part of Marechale's success fee, the Company secures warrants or equity on most of its projects, so shareholders can share in the potential significant upside of the equity value in these businesses.

 

Whilst market conditions are still challenging, and we remain cautious about the immediate outlook, there is a good pipeline of businesses seeking funding, a number of engaged corporate finance projects, and an appetite amongst our investor contacts to invest in high quality investment opportunities. This provides us with a degree of confidence for the second half of the trading year.

 

We hope to give you further positive updates on Marechale after the March 2012 year end.

 

Mark Warde-Norbury

Chairman

20 December 2011

 

 

 

For further information please contact:

 

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

 

Tel: +44 (0)20 7628 5582

Smith & Williamson Corporate Finance

Azhic Basirov / David Jones

 

Tel: +44 (0)20 7131 4000

 

 

 

 

 

 

 

Marechale Capital plc

 

 

Income Statement (unaudited)

 

Six months ended 30 September 2011

 

30 Sept

30 Sept

 

2011

2010

 

 

Revenue

237,319

299,658

 

Cost of sales

(25,940)

(25,343)

 

 

Gross profit

211,379

274,315

 

 

Administrative expenses

(297,235)

(264,935)

 

 

Operating (loss)/profit

(85,856)

9,380

 

 

Investment revenues

39

646

 

Other gains and losses

-

-

 

 

Loss/ profit before tax

(85,817)

10,026

 

 

Corporation tax charge

-

-

 

 

(Loss)/ profit for the period

(85,817)

10,026

 

 

 

Earnings per share (Basic and diluted)

52,437,410 shares (2010: 47,437,410)

 

(0.16p)

 

0.02p

 

 

 

 

Balance Sheet (unaudited)

 

As at 30 September 2011

 

30 Sept

30 Sept

 

2011

2010

 

Non-current assets

 

Property, plant and equipment

-

-

 

 

Current assets

 

Available for sale investments

76,351

67,707

 

Trading investments

28,125

-

 

Trade and other receivables

41,608

144,848

 

Cash and cash equivalents

284,870

294,156

 

 

430,954

506,711

 

Total assets

430,954

506,711

 

 

Current liabilities

 

Trade and other payables

(47,771)

(94,682)

 

Corporation tax

-

-

 

 

Total current liabilities

(47,771)

(94,682)

 

 

Net assets

383,183

412,029

 

 

 

Equity

 

Share capital

2,421,871

2,371,872

 

Share premium account

1,227,452

1,177,452

 

Revaluation reserves

21,602

28,324

 

Other reserves

(50,254)

(50,254)

 

Retained earnings

(3,237,488)

(3,115,365)

 

 

Total equity

383,183

412,029

 

 

 

 

Cash Flow Statement (unaudited)

 

Six months ended 30 September 2011

 

30 Sept

30 Sept

 

2011

2010

 

Net cash from operating activities

 

Operating (loss)/ profit

(85,855)

9,380

 

 

Operating cash flows before movements in working capital

(85,855)

9,380

Movement in working capital

 

Decrease/ (increase) in receivables

40,874

(81,874)

 

(Decrease)/ increase in payables

(751)

(23,428)

 

 

40,123

(105,302)

 

Operating cash flow

(45,732)

(95,922)

 

 

Investment activities

 

Interest receivable

38

646

 

Proceeds on disposal of trading investments

-

-

 

Proceeds on disposal of available for sale investments

-

-

 

Expenditure on tangible fixed assets

-

-

 

Expenditure on trading investments

(11,500)

(10,000)

 

 

Cash flow from investing activities

(11,462)

(9,354)

 

 

Financing

 

Issue of share capital

100,000

-

 

Interest payable

-

-

 

 

Cash flow from financing activities

-

-

 

 

Net increase/(decrease) in cash and cash equivalents

42,806

(105,276)

 

 

Cash and cash equivalents at start of period

242,064

399,432

 

Cash and cash equivalents at end of period

284,870

294,156

 

 

Increase/(decrease) in cash and cash equivalents

42,806

(105,276)

 

 

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior periods being reported on the same basis.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR DBLFLFLFBFBE
Date   Source Headline
2nd Oct 20207:00 amRNSChange of Adviser
28th Sep 20201:20 pmRNSPosting of Annual Report and Notice of AGM
25th Aug 202010:39 amRNSHolding(s) in Company
24th Aug 20207:00 amRNSFinal Results
10th Aug 202010:03 amRNSHolding(s) in Company
7th Aug 20201:05 pmRNSHolding(s) in Company
6th Aug 202010:09 amRNSHolding(s) in Company
5th Aug 202011:35 amRNSHolding(s) in Company
4th Aug 20201:03 pmRNSHolding(s) in Company
30th Jul 20204:40 pmRNSSecond Price Monitoring Extn
30th Jul 20204:35 pmRNSPrice Monitoring Extension
17th Jan 20203:31 pmRNSHolding(s) in Company
12th Dec 20193:08 pmRNSHalf-year Report
24th Sep 201912:16 pmRNSHolding(s) in Company
23rd Sep 20193:38 pmRNSResult of AGM
2nd Sep 20192:46 pmRNSPosting of Annual Report and Notice of AGM
29th Aug 20193:48 pmRNSFinal Results
12th Jul 20191:45 pmRNSBoard Change
1st May 201912:39 pmRNSTrading Statement
25th Jan 201910:16 amRNSInterim Results
12th Dec 20187:00 amRNSChange of Adviser
28th Nov 20185:18 pmRNSChange of Adviser
8th Nov 20183:16 pmRNSDirector/PDMR Shareholding
4th Oct 20182:11 pmRNSResult of AGM
13th Sep 20189:50 amRNSPosting of Annual Report and Notice of AGM
21st Aug 20186:13 pmRNSHolding(s) in Company
21st Aug 201811:35 amRNSFinal Results
5th Jul 20181:55 pmRNSHolding(s) in Company
16th Apr 20182:04 pmRNSHolding(s) in Company
7th Mar 20182:19 pmRNSDirector/PDMR Shareholding
29th Jan 20187:00 amRNSInterim Results
25th Jan 20182:25 pmRNSHolding(s) in Company
8th Dec 201712:01 pmRNSHolding(s) in Company
9th Nov 20175:01 pmRNSTrading Update
14th Sep 201710:57 amRNSResult of AGM
18th Aug 20173:59 pmRNSPosting of Annual Report and Notice of AGM
14th Aug 201712:20 pmRNSDirector/PDMR Shareholding
27th Jul 20177:00 amRNSFinal Results
25th Jan 20171:50 pmRNSCapital reduction update
22nd Dec 201611:37 amRNSDirector/PDMR Shareholding
16th Dec 20167:00 amRNSHalf-year Report
15th Sep 20161:13 pmRNSDirector/PDMR Shareholding
14th Sep 201612:54 pmRNSResult of AGM
24th Aug 20164:36 pmRNSPosting of Annual Report & Notice of AGM
25th Jul 20167:00 amRNSFinal Results
4th May 201611:42 amRNSStmnt re Share Price Movement
20th Jan 20163:14 pmRNSDirectorate Change
19th Jan 20161:11 pmRNSStmnt re Share Price Movement
17th Dec 20157:00 amRNSHalf Yearly Report
19th Nov 20155:30 pmRNSNorthfield UK Solar Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.